Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port" ...

Age-related macular degeneration (AMD) once meant a slow, irreversible loss of vision, and many people still believe that's ...

Latest treatments for Age-related Macular Degeneration (AMD) are giving hope to thousands of people living with the condition.

Both anti-VEGF and surgical treatments improve VA in AMD-related submacular hemorrhage, with no statistically significant difference between the two treatments. Anti-VEGF injections may be associated ...

Researchers think they know why eye injections for “wet” AMD sometimes fail The eye injections actually increase a protein linked to new blood vessel growth An experimental drug reduced levels of ...

Researchers at Science Tokyo developed an mRNA vaccine that suppressed abnormal retinal blood vessel growth in mouse models. The vaccine can be administered intramuscularly and showed effectiveness ...

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the most common cause of blindness in western ...

Concerns arise as Medisep 2 excludes essential eye treatment for age-related macular degeneration, risking vision for Kerala’s pensioners.

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western ...